One-time surgical application of genetically engineered autologous keratinocyte sheets provides significant closure and pain ...

Of the 43 large, chronic wounds treated with one pz-cel application, 81% of wounds showed 50% or more healing (P < .0001) at 6 months, compared with 16% of the 43 matched control wounds treated ...

At the same time point, 65% of treated wounds were at least three-quarters healed, ... The grafts she received in the clinical trial have helped heal several large, open wounds on her thigh, ...

Scientists discovered that nanosilicates can help the body grow new blood vessels, which is essential for healing wounds and ...

By week 24, results showed that 81% of the wounds treated with prademagene zamikeracel were at least 50% healed from baseline vs. 16% of the control wounds. At the same time point, 65% of the ...

SIUH’s Wound Care Center is built in partnership with Healogics, a nationally recognized leader in wound management. With a ...

At the same time point, 65% of treated wounds were at least three-quarters healed, ... The grafts she received in the clinical trial have helped heal several large, open wounds on her thigh, ...

She describes the sensation from EB wounds that have not been treated with the skin grafts “like being burned all the time, almost like being submerged in lava.” The grafts she received in the ...

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.